Pfizer Key Ratios (2009-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Oct2021	Dec2021	Apr2022	Jul2022	Sep2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Profitability
Gross Margin (Quarter)	63.30%		61.09%	68.83%			-34.71%	7.25%		-120.24%	77.29%	68.97%	73.96%		79.26%	-66.21%	74.95%	114.74%	75.45%	72.78%
EBT Margin (Quarter)	35.66%		35.27%	41.26%			172.87%	65.01%		-120.24%	22.99%	-0.97%	17.51%		20.31%	133.92%	20.02%	4.59%	21.94%	-4.34%
EBIT Margin (Quarter)	35.15%		41.27%	47.01%			-196.80%	-172.78%		-410.16%	36.36%	-1.70%	30.55%		36.57%	-324.86%	39.11%	136.21%	37.39%	28.37%
EBITDA Margin (Quarter)	35.15%		41.27%	47.01%			-196.80%	-172.78%		-410.16%	36.36%	-1.70%	30.55%		36.57%	-324.86%	39.11%	136.21%	37.39%	28.37%
Operating Margin (Quarter)	35.15%		41.27%	47.01%			-196.80%	-172.78%		-410.16%	36.36%	-1.70%	30.55%		36.57%	-324.86%	39.11%	136.21%	37.39%	28.37%
Net Margin (Quarter)	-0.43%		-0.04%	0.12%			0.03%	-0.06%		-0.76%	-0.03%	0.16%	-0.02%			1.10%			-0.09%	0.05%
FCF Margin (Quarter)	44.01%		22.98%	26.74%			2.01%	-60.80%		122.19%	2.59%	-22.73%	8.79%		12.91%	-52.79%	24.02%	-12.59%	15.08%	2.01%
Efficiency
Inventory Average (Quarter)	8.79B	8.85B	9.52B	10.22B			9.26B	9.93B			10.54B	11.17B	11.58B	11.29B	10.85B	11.26B	11.57B	11.06B	10.66B	10.31B
Assets Average (Quarter)	108.13B	113.67B	182.42B	189.57B	118.21B	119.07B	196.50B	208.08B	131.50B	134.91B	224.05B	218.55B	217.74B	216.24B	210.51B	207.06B	207.41B	208.37B	208.00B	204.57B
Invested Capital (Quarter)	3.63B	2.24B	0.65B	5.99B		2.94B	4.19B	3.98B		10.35B	8.23B	11.94B	9.70B	6.95B	4.47B	4.29B	4.30B	3.15B	3.89B	2.70B
Asset Utilization Ratio (Quarter)	1.12	0.83	0.58	0.60		0.50	0.31	0.18		0.10	0.11	0.15	0.34		0.40	0.35	0.38	-0.01	-0.01	0.31
Leverage & Solvency
Interest Coverage Ratio (Quarter)	16.76		23.38	44.51			-17.04	-11.87		-13.34	6.85	-0.23	5.96		7.67	-11.29	9.99	-62.52	8.09	6.39
Debt Ratio (Quarter)	0.86	0.21	0.20	0.21		0.18	0.18	0.30		0.32	0.31	0.32	0.31	0.30	0.30	0.30	0.30	0.31	0.31	0.31
Times Interest Earned (Quarter)	16.76		23.38	44.51			-17.04	-11.87		-13.34	6.85	-0.23	5.96		7.67	-11.29	9.99	-62.52	8.09	6.39
Dividends & Payouts
FCF Payout Ratio (Quarter)	0.26		0.38	0.30			31.55	-1.09		0.55	6.15	-0.98	1.77		1.38	-2.04	0.61	0.54	1.12	8.12
Valuation
Enterprise Value (Quarter)	-29.42B	-30.81B	-23.64B	-33.04B	0.23B	-22.48B	-19.71B	-44.51B	0.25B	-12.42B	-11.65B	-6.83B	-9.68B	-20.18B	-17.02B	-12.93B	-14.69B	-13.30B	-12.77B	-11.40B
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	41.43%		30.10%	35.57%			22.94%	6.03%		-16.31%	-11.90%	-8.52%	2.95%		13.93%	6.77%	10.63%	-26.00%	-25.44%	11.86%
Return on Invested Capital (Quarter)	0.02%		0.03%	0.04%			0.03%	0.01%		-0.01%	-0.01%	-0.01%	0.00%		0.01%	0.00%	0.01%	-0.03%	-0.03%	0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Datasets

Plans

Developers

Pfizer PFE Ratios (2009-2026)

Research Tools

Datasets

Plans

Developers

Pfizer PFE Ratios (2009-2026)

Create an account

Sign In

Reset Password